Rank | Gene Set | Z-score |
---|---|---|
1 | fusion of sperm to egg plasma membrane (GO:0007342) | 5.39291717 |
2 | plasma membrane fusion (GO:0045026) | 4.58060115 |
3 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.45087478 |
4 | acrosome assembly (GO:0001675) | 4.28168646 |
5 | sperm motility (GO:0030317) | 4.25211238 |
6 | cell wall macromolecule catabolic process (GO:0016998) | 4.18803003 |
7 | cell wall macromolecule metabolic process (GO:0044036) | 4.18803003 |
8 | multicellular organism reproduction (GO:0032504) | 4.06005186 |
9 | actin-myosin filament sliding (GO:0033275) | 3.75334230 |
10 | muscle filament sliding (GO:0030049) | 3.75334230 |
11 | reproduction (GO:0000003) | 3.66264599 |
12 | acrosome reaction (GO:0007340) | 3.62805580 |
13 | low-density lipoprotein particle clearance (GO:0034383) | 3.61503949 |
14 | plasma membrane repair (GO:0001778) | 3.59846844 |
15 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.54076034 |
16 | regulation of sequestering of triglyceride (GO:0010889) | 3.45930840 |
17 | sperm-egg recognition (GO:0035036) | 3.38271916 |
18 | protein localization to endosome (GO:0036010) | 3.32074873 |
19 | positive regulation of myotube differentiation (GO:0010831) | 3.20065453 |
20 | actin-mediated cell contraction (GO:0070252) | 3.18447134 |
21 | regulation of skeletal muscle contraction (GO:0014819) | 3.12824995 |
22 | sperm capacitation (GO:0048240) | 3.12450262 |
23 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.10641867 |
24 | cell-cell recognition (GO:0009988) | 3.10631414 |
25 | carnitine transmembrane transport (GO:1902603) | 3.10385886 |
26 | sarcomere organization (GO:0045214) | 3.09547452 |
27 | detection of molecule of bacterial origin (GO:0032490) | 3.09408887 |
28 | cell adhesion mediated by integrin (GO:0033627) | 3.05546780 |
29 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.04222228 |
30 | membrane raft organization (GO:0031579) | 2.96663300 |
31 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.96274914 |
32 | growth hormone receptor signaling pathway (GO:0060396) | 2.94193572 |
33 | carnitine transport (GO:0015879) | 2.91731934 |
34 | amino-acid betaine transport (GO:0015838) | 2.91731934 |
35 | epithelial cilium movement (GO:0003351) | 2.91399910 |
36 | carnitine shuttle (GO:0006853) | 2.89092655 |
37 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.87794817 |
38 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.85422966 |
39 | fatty acid transmembrane transport (GO:1902001) | 2.84301955 |
40 | positive regulation of receptor recycling (GO:0001921) | 2.81535367 |
41 | creatine metabolic process (GO:0006600) | 2.80086833 |
42 | axonemal dynein complex assembly (GO:0070286) | 2.77367333 |
43 | binding of sperm to zona pellucida (GO:0007339) | 2.75690664 |
44 | response to lipoprotein particle (GO:0055094) | 2.75673729 |
45 | negative regulation of inclusion body assembly (GO:0090084) | 2.71686974 |
46 | motile cilium assembly (GO:0044458) | 2.70299832 |
47 | cellular response to epinephrine stimulus (GO:0071872) | 2.69082720 |
48 | actin filament-based movement (GO:0030048) | 2.68650073 |
49 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.63858313 |
50 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.62848148 |
51 | regulation of p38MAPK cascade (GO:1900744) | 2.62162223 |
52 | regulation of relaxation of muscle (GO:1901077) | 2.62151636 |
53 | barbed-end actin filament capping (GO:0051016) | 2.61094494 |
54 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.60436769 |
55 | cellular response to growth hormone stimulus (GO:0071378) | 2.58633904 |
56 | positive regulation of macrophage cytokine production (GO:0060907) | 2.58381336 |
57 | cortical actin cytoskeleton organization (GO:0030866) | 2.58314439 |
58 | cellular extravasation (GO:0045123) | 2.57382213 |
59 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.55445169 |
60 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.55445169 |
61 | modulation by symbiont of host immune response (GO:0052553) | 2.55445169 |
62 | positive regulation by symbiont of host defense response (GO:0052509) | 2.55445169 |
63 | modulation by symbiont of host defense response (GO:0052031) | 2.55445169 |
64 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.55445169 |
65 | spermatid development (GO:0007286) | 2.55031153 |
66 | regulation of cholesterol storage (GO:0010885) | 2.54651073 |
67 | glomerular filtration (GO:0003094) | 2.53652194 |
68 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.52317641 |
69 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.52064902 |
70 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.51692766 |
71 | negative regulation of cell killing (GO:0031342) | 2.51692766 |
72 | skeletal muscle fiber development (GO:0048741) | 2.51293536 |
73 | stress fiber assembly (GO:0043149) | 2.51089487 |
74 | skeletal muscle contraction (GO:0003009) | 2.50418838 |
75 | germinal center formation (GO:0002467) | 2.48787991 |
76 | myelin maintenance (GO:0043217) | 2.48099330 |
77 | cellular response to arsenic-containing substance (GO:0071243) | 2.47502284 |
78 | renal filtration (GO:0097205) | 2.46826454 |
79 | import into cell (GO:0098657) | 2.45928148 |
80 | positive regulation of p38MAPK cascade (GO:1900745) | 2.45339560 |
81 | response to inactivity (GO:0014854) | 2.45182589 |
82 | muscle cell fate commitment (GO:0042693) | 2.45054192 |
83 | semaphorin-plexin signaling pathway (GO:0071526) | 2.43518652 |
84 | response to peptidoglycan (GO:0032494) | 2.43286809 |
85 | myofibril assembly (GO:0030239) | 2.38904143 |
86 | intracellular lipid transport (GO:0032365) | 2.38038564 |
87 | apoptotic cell clearance (GO:0043277) | 2.37789252 |
88 | striated muscle atrophy (GO:0014891) | 2.37365370 |
89 | fibril organization (GO:0097435) | 2.37077882 |
90 | detection of external biotic stimulus (GO:0098581) | 2.36277742 |
91 | macrophage activation involved in immune response (GO:0002281) | 2.36099660 |
92 | neutrophil activation involved in immune response (GO:0002283) | 2.35795757 |
93 | response to epinephrine (GO:0071871) | 2.34463412 |
94 | ruffle organization (GO:0031529) | 2.34396287 |
95 | single fertilization (GO:0007338) | 2.33986119 |
96 | nerve growth factor signaling pathway (GO:0038180) | 2.31792800 |
97 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.31431161 |
98 | regulation of macrophage cytokine production (GO:0010935) | 2.31263422 |
99 | detection of other organism (GO:0098543) | 2.30063310 |
100 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.30055604 |
101 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.29641301 |
102 | myoblast fusion (GO:0007520) | 2.29102239 |
103 | negative regulation of fatty acid transport (GO:2000192) | 2.29046972 |
104 | syncytium formation (GO:0006949) | 2.28985279 |
105 | hypotonic response (GO:0006971) | 2.28870077 |
106 | cardiac myofibril assembly (GO:0055003) | 2.28304250 |
107 | membrane protein ectodomain proteolysis (GO:0006509) | 2.28141762 |
108 | collagen fibril organization (GO:0030199) | 2.27741986 |
109 | sexual reproduction (GO:0019953) | 2.27172546 |
110 | positive regulation of histone deacetylation (GO:0031065) | 2.26834972 |
111 | negative regulation of interleukin-12 production (GO:0032695) | 2.25470008 |
112 | cortical cytoskeleton organization (GO:0030865) | 2.25167056 |
113 | localization within membrane (GO:0051668) | 2.24385247 |
114 | cilium movement (GO:0003341) | 2.24134369 |
115 | macroautophagy (GO:0016236) | 2.22955913 |
116 | extracellular fibril organization (GO:0043206) | 2.22169595 |
117 | skin morphogenesis (GO:0043589) | 2.21025337 |
118 | protein heterotrimerization (GO:0070208) | 2.20981664 |
119 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.19297385 |
120 | brown fat cell differentiation (GO:0050873) | 2.18798484 |
121 | Rap protein signal transduction (GO:0032486) | 2.18157173 |
122 | cellular response to osmotic stress (GO:0071470) | 2.17479625 |
123 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.17009546 |
124 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.16988774 |
125 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.16851267 |
126 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.16844300 |
127 | endothelium development (GO:0003158) | 2.16561085 |
128 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.15987013 |
129 | heart trabecula formation (GO:0060347) | 2.15809200 |
130 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.15048151 |
131 | regulation of receptor recycling (GO:0001919) | 2.14608220 |
132 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.14597285 |
133 | basement membrane organization (GO:0071711) | 2.14435460 |
134 | blood vessel maturation (GO:0001955) | 2.13174490 |
135 | endodermal cell differentiation (GO:0035987) | 2.12949863 |
136 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.11771473 |
137 | hippo signaling (GO:0035329) | 2.11743865 |
138 | endothelial cell morphogenesis (GO:0001886) | 2.11152460 |
139 | regulation of necroptotic process (GO:0060544) | 2.10926755 |
140 | response to muramyl dipeptide (GO:0032495) | 2.10743249 |
141 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.10474557 |
142 | response to host (GO:0075136) | 2.10249953 |
143 | response to host defenses (GO:0052200) | 2.10249953 |
144 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.10249953 |
145 | actomyosin structure organization (GO:0031032) | 2.09540363 |
146 | response to host immune response (GO:0052572) | 2.09331209 |
147 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.09331209 |
148 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.08051863 |
149 | macrophage activation (GO:0042116) | 2.07609457 |
150 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.07454382 |
151 | negative regulation of anoikis (GO:2000811) | 2.06004439 |
152 | negative regulation of lipid storage (GO:0010888) | 2.05650785 |
153 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.03786170 |
154 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.02371696 |
155 | wound healing, spreading of epidermal cells (GO:0035313) | 1.99917088 |
156 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 1.99356506 |
157 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 1.99206730 |
158 | response to laminar fluid shear stress (GO:0034616) | 1.98969535 |
159 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 1.98876221 |
160 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 1.98790999 |
161 | regulation of transforming growth factor beta2 production (GO:0032909) | 1.94357074 |
162 | venous blood vessel morphogenesis (GO:0048845) | 1.93729645 |
163 | detection of biotic stimulus (GO:0009595) | 1.93549064 |
164 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 1.93473022 |
165 | cellular response to thyroid hormone stimulus (GO:0097067) | 1.93222064 |
166 | negative regulation of protein localization to cell surface (GO:2000009) | 1.92218601 |
167 | regulation of platelet aggregation (GO:0090330) | 1.91845910 |
168 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 1.91077080 |
169 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 1.89416066 |
170 | substrate-dependent cell migration (GO:0006929) | 1.88467841 |
171 | regulation of platelet activation (GO:0010543) | 1.88405439 |
172 | negative regulation of interleukin-17 production (GO:0032700) | 1.88125489 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.98886046 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.80466791 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.65345924 |
4 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.33229372 |
5 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.16767563 |
6 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.05256431 |
7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.98895727 |
8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.95193882 |
9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95167655 |
10 | CJUN_26792858_Chip-Seq_BT549_Human | 1.89235810 |
11 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.87982810 |
12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.83931464 |
13 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.83166677 |
14 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.78011141 |
15 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.74411655 |
16 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.74411655 |
17 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.71875315 |
18 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.71638918 |
19 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.65062864 |
20 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.63371869 |
21 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.61348402 |
22 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.61255942 |
23 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.60413969 |
24 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.59499590 |
25 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.59044335 |
26 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57287807 |
27 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.57250190 |
28 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.55538581 |
29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.55286510 |
30 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.55185061 |
31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53625665 |
32 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.52502269 |
33 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.51812393 |
34 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.49997301 |
35 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.47281660 |
36 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.44257479 |
37 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.44257479 |
38 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.41186431 |
39 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38383811 |
40 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36840164 |
41 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.36712315 |
42 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.36143444 |
43 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.34518904 |
44 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.33074393 |
45 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.32539555 |
46 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.32501010 |
47 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.31448824 |
48 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.30065472 |
49 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.28304638 |
50 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.20542834 |
51 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17522820 |
52 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.17393305 |
53 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15365339 |
54 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.15283579 |
55 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.15283579 |
56 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14455278 |
57 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.14307325 |
58 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14270967 |
59 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.14144984 |
60 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12065441 |
61 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.11189666 |
62 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.10832710 |
63 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.10148945 |
64 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.08060363 |
65 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07403280 |
66 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.06605671 |
67 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.05750996 |
68 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.05605770 |
69 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04430702 |
70 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.04359825 |
71 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.03415359 |
72 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01730209 |
73 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01041342 |
74 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.00670936 |
75 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.00563413 |
76 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00285907 |
77 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.00127185 |
78 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99838611 |
79 | TP53_16413492_ChIP-PET_HCT116_Human | 0.99326050 |
80 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.98471425 |
81 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.97452512 |
82 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.96902648 |
83 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.95919314 |
84 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95864729 |
85 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.95154030 |
86 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.93990024 |
87 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.93657161 |
88 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.93477761 |
89 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93220257 |
90 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.93118537 |
91 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.93013389 |
92 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92931642 |
93 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92014538 |
94 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.90133674 |
95 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.89732691 |
96 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.89525273 |
97 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.89525273 |
98 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.89426556 |
99 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.89095956 |
100 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.88900792 |
101 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.88646702 |
102 | SPI1_23127762_ChIP-Seq_K562_Human | 0.88398255 |
103 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.87794792 |
104 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87747613 |
105 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.86355868 |
106 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.86296215 |
107 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86191897 |
108 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.85760655 |
109 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85650925 |
110 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.85551672 |
111 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.85106609 |
112 | GATA1_22025678_ChIP-Seq_K562_Human | 0.84648695 |
113 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.84613465 |
114 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.84409502 |
115 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.83497959 |
116 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82926489 |
117 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.82782420 |
118 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82488712 |
119 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.82437499 |
120 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.82174586 |
121 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.81934054 |
122 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.81454429 |
123 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.81387223 |
124 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.81237625 |
125 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.81130847 |
126 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.80398153 |
127 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.80300926 |
128 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.80098450 |
129 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.78912114 |
130 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.78443490 |
131 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.78384027 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008438_abnormal_cutaneous_collagen | 4.19276555 |
2 | MP0005410_abnormal_fertilization | 3.81624508 |
3 | MP0004130_abnormal_muscle_cell | 2.83575789 |
4 | MP0003950_abnormal_plasma_membrane | 2.70563436 |
5 | MP0000749_muscle_degeneration | 2.65784684 |
6 | MP0000733_abnormal_muscle_development | 2.62482465 |
7 | MP0000751_myopathy | 2.58724230 |
8 | MP0005275_abnormal_skin_tensile | 2.52255294 |
9 | MP0004185_abnormal_adipocyte_glucose | 2.45098113 |
10 | MP0005623_abnormal_meninges_morphology | 2.40634354 |
11 | MP0005666_abnormal_adipose_tissue | 2.39273533 |
12 | MP0005670_abnormal_white_adipose | 2.35804917 |
13 | MP0000750_abnormal_muscle_regeneration | 2.23844954 |
14 | MP0004087_abnormal_muscle_fiber | 2.20163614 |
15 | MP0003705_abnormal_hypodermis_morpholog | 2.14641925 |
16 | MP0004272_abnormal_basement_membrane | 2.04249145 |
17 | MP0004084_abnormal_cardiac_muscle | 1.99409697 |
18 | MP0002837_dystrophic_cardiac_calcinosis | 1.93804372 |
19 | MP0005375_adipose_tissue_phenotype | 1.93261848 |
20 | MP0002332_abnormal_exercise_endurance | 1.92655132 |
21 | MP0003279_aneurysm | 1.92015687 |
22 | MP0003300_gastrointestinal_ulcer | 1.86610492 |
23 | MP0004036_abnormal_muscle_relaxation | 1.80612267 |
24 | MP0002971_abnormal_brown_adipose | 1.79895460 |
25 | MP0000759_abnormal_skeletal_muscle | 1.71655785 |
26 | MP0002106_abnormal_muscle_physiology | 1.70806975 |
27 | MP0000747_muscle_weakness | 1.69612797 |
28 | MP0005451_abnormal_body_composition | 1.68733065 |
29 | MP0003828_pulmonary_edema | 1.68573810 |
30 | MP0005330_cardiomyopathy | 1.65606167 |
31 | MP0004145_abnormal_muscle_electrophysio | 1.65054891 |
32 | MP0005503_abnormal_tendon_morphology | 1.61473242 |
33 | MP0001879_abnormal_lymphatic_vessel | 1.61012448 |
34 | MP0003646_muscle_fatigue | 1.59382778 |
35 | MP0003303_peritoneal_inflammation | 1.50561869 |
36 | MP0000465_gastrointestinal_hemorrhage | 1.50162211 |
37 | MP0000013_abnormal_adipose_tissue | 1.49010349 |
38 | MP0002877_abnormal_melanocyte_morpholog | 1.48565710 |
39 | MP0000343_altered_response_to | 1.48043206 |
40 | MP0010630_abnormal_cardiac_muscle | 1.46988653 |
41 | MP0000920_abnormal_myelination | 1.46982541 |
42 | MP0003091_abnormal_cell_migration | 1.46605044 |
43 | MP0005620_abnormal_muscle_contractility | 1.45692415 |
44 | MP0005369_muscle_phenotype | 1.45631424 |
45 | MP0001958_emphysema | 1.43637192 |
46 | MP0003566_abnormal_cell_adhesion | 1.43594390 |
47 | MP0002108_abnormal_muscle_morphology | 1.42654005 |
48 | MP0000003_abnormal_adipose_tissue | 1.41758655 |
49 | MP0002972_abnormal_cardiac_muscle | 1.41603886 |
50 | MP0005164_abnormal_response_to | 1.40131467 |
51 | MP0005409_darkened_coat_color | 1.36179126 |
52 | MP0000569_abnormal_digit_pigmentation | 1.35024218 |
53 | MP0004510_myositis | 1.33830882 |
54 | MP0008775_abnormal_heart_ventricle | 1.32736114 |
55 | MP0001835_abnormal_antigen_presentation | 1.32580708 |
56 | MP0003724_increased_susceptibility_to | 1.32026008 |
57 | MP0005464_abnormal_platelet_physiology | 1.30493446 |
58 | MP0001299_abnormal_eye_distance/ | 1.27030832 |
59 | MP0010368_abnormal_lymphatic_system | 1.25096291 |
60 | MP0009785_altered_susceptibility_to | 1.24263777 |
61 | MP0004883_abnormal_blood_vessel | 1.23905947 |
62 | MP0005058_abnormal_lysosome_morphology | 1.23055346 |
63 | MP0003045_fibrosis | 1.21874574 |
64 | MP0003690_abnormal_glial_cell | 1.21626597 |
65 | MP0009278_abnormal_bone_marrow | 1.19539648 |
66 | MP0006138_congestive_heart_failure | 1.19193485 |
67 | MP0001533_abnormal_skeleton_physiology | 1.18762547 |
68 | MP0002998_abnormal_bone_remodeling | 1.18114109 |
69 | MP0001544_abnormal_cardiovascular_syste | 1.16626117 |
70 | MP0005385_cardiovascular_system_phenoty | 1.16626117 |
71 | MP0004215_abnormal_myocardial_fiber | 1.16177359 |
72 | MP0006054_spinal_hemorrhage | 1.14865297 |
73 | MP0008004_abnormal_stomach_pH | 1.14424183 |
74 | MP0009384_cardiac_valve_regurgitation | 1.12595473 |
75 | MP0005165_increased_susceptibility_to | 1.11541677 |
76 | MP0000767_abnormal_smooth_muscle | 1.09778811 |
77 | MP0005387_immune_system_phenotype | 1.07884174 |
78 | MP0001790_abnormal_immune_system | 1.07884174 |
79 | MP0002148_abnormal_hypersensitivity_rea | 1.07613564 |
80 | MP0002269_muscular_atrophy | 1.07314699 |
81 | MP0002295_abnormal_pulmonary_circulatio | 1.06500386 |
82 | MP0004134_abnormal_chest_morphology | 1.06455492 |
83 | MP0009764_decreased_sensitivity_to | 1.05590987 |
84 | MP0005000_abnormal_immune_tolerance | 1.02817135 |
85 | MP0003075_altered_response_to | 1.02594731 |
86 | MP0002127_abnormal_cardiovascular_syste | 1.02053921 |
87 | MP0004233_abnormal_muscle_weight | 0.99856214 |
88 | MP0003448_altered_tumor_morphology | 0.98105422 |
89 | MP0003656_abnormal_erythrocyte_physiolo | 0.97977709 |
90 | MP0005595_abnormal_vascular_smooth | 0.96684187 |
91 | MP0005166_decreased_susceptibility_to | 0.96285505 |
92 | MP0002933_joint_inflammation | 0.94755228 |
93 | MP0005025_abnormal_response_to | 0.94070818 |
94 | MP0009840_abnormal_foam_cell | 0.93423486 |
95 | MP0002896_abnormal_bone_mineralization | 0.92238812 |
96 | MP0009115_abnormal_fat_cell | 0.91443285 |
97 | MP0002166_altered_tumor_susceptibility | 0.90207486 |
98 | MP0002128_abnormal_blood_circulation | 0.88570819 |
99 | MP0003221_abnormal_cardiomyocyte_apopto | 0.87423360 |
100 | MP0008260_abnormal_autophagy | 0.87187181 |
101 | MP0005076_abnormal_cell_differentiation | 0.86082560 |
102 | MP0000858_altered_metastatic_potential | 0.86069646 |
103 | MP0004484_altered_response_of | 0.84612405 |
104 | MP0005167_abnormal_blood-brain_barrier | 0.83759647 |
105 | MP0001542_abnormal_bone_strength | 0.83585000 |
106 | MP0003191_abnormal_cellular_cholesterol | 0.82346352 |
107 | MP0004947_skin_inflammation | 0.82309976 |
108 | MP0003436_decreased_susceptibility_to | 0.81708829 |
109 | MP0005334_abnormal_fat_pad | 0.81684775 |
110 | MP0010352_gastrointestinal_tract_polyps | 0.80927107 |
111 | MP0009780_abnormal_chondrocyte_physiolo | 0.80546648 |
112 | MP0006082_CNS_inflammation | 0.79511372 |
113 | MP0001851_eye_inflammation | 0.78609566 |
114 | MP0000249_abnormal_blood_vessel | 0.78503571 |
115 | MP0001614_abnormal_blood_vessel | 0.75362630 |
116 | MP0009250_abnormal_appendicular_skeleto | 0.74878929 |
117 | MP0005388_respiratory_system_phenotype | 0.73427916 |
118 | MP0002133_abnormal_respiratory_system | 0.73427916 |
119 | MP0002060_abnormal_skin_morphology | 0.72015575 |
120 | MP0003698_abnormal_male_reproductive | 0.71110758 |
121 | MP0002419_abnormal_innate_immunity | 0.70897863 |
122 | MP0002168_other_aberrant_phenotype | 0.69570539 |
123 | MP0004147_increased_porphyrin_level | 0.69184137 |
124 | MP0000685_abnormal_immune_system | 0.69107342 |
125 | MP0005390_skeleton_phenotype | 0.68731871 |
126 | MP0005023_abnormal_wound_healing | 0.66130500 |
127 | MP0002234_abnormal_pharynx_morphology | 0.64952406 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.66569157 |
2 | Difficulty running (HP:0009046) | 4.66480118 |
3 | Muscle fiber inclusion bodies (HP:0100299) | 4.56465141 |
4 | Muscle fiber splitting (HP:0003555) | 4.45767458 |
5 | Hyporeflexia of lower limbs (HP:0002600) | 4.34480556 |
6 | Type 1 muscle fiber predominance (HP:0003803) | 4.34228033 |
7 | Nemaline bodies (HP:0003798) | 4.16726030 |
8 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.90507584 |
9 | Absent/shortened dynein arms (HP:0200106) | 3.83960711 |
10 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.83960711 |
11 | Round ear (HP:0100830) | 3.54995669 |
12 | Distal arthrogryposis (HP:0005684) | 3.51475525 |
13 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.45211076 |
14 | Gowers sign (HP:0003391) | 3.44016514 |
15 | Premature rupture of membranes (HP:0001788) | 3.43794455 |
16 | Increased connective tissue (HP:0009025) | 3.40650543 |
17 | Calf muscle hypertrophy (HP:0008981) | 3.40448119 |
18 | Difficulty climbing stairs (HP:0003551) | 3.34778870 |
19 | Exercise-induced myalgia (HP:0003738) | 3.30883995 |
20 | Abnormality of the calf musculature (HP:0001430) | 3.22812497 |
21 | Spinal rigidity (HP:0003306) | 3.18172683 |
22 | Exercise-induced muscle cramps (HP:0003710) | 3.17685344 |
23 | Ulnar deviation of the wrist (HP:0003049) | 3.06797176 |
24 | EMG: myopathic abnormalities (HP:0003458) | 2.98938610 |
25 | Spontaneous hematomas (HP:0007420) | 2.94561875 |
26 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.79989627 |
27 | Scapular winging (HP:0003691) | 2.76753202 |
28 | Increased variability in muscle fiber diameter (HP:0003557) | 2.76678572 |
29 | Abnormality of the neuromuscular junction (HP:0003398) | 2.75693221 |
30 | Fatigable weakness (HP:0003473) | 2.75693221 |
31 | Eczematoid dermatitis (HP:0000976) | 2.74729756 |
32 | Asymmetric septal hypertrophy (HP:0001670) | 2.71840545 |
33 | Weak cry (HP:0001612) | 2.70718829 |
34 | Easy fatigability (HP:0003388) | 2.66509642 |
35 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.63260317 |
36 | Protrusio acetabuli (HP:0003179) | 2.62700399 |
37 | Facial diplegia (HP:0001349) | 2.59328105 |
38 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.58001774 |
39 | Osteolytic defects of the hand bones (HP:0009699) | 2.58001774 |
40 | Myoglobinuria (HP:0002913) | 2.55618378 |
41 | Aortic aneurysm (HP:0004942) | 2.55150023 |
42 | Abnormality of the nasal mucosa (HP:0000433) | 2.53270231 |
43 | Nasal polyposis (HP:0100582) | 2.52936037 |
44 | Bundle branch block (HP:0011710) | 2.51807146 |
45 | Generalized muscle weakness (HP:0003324) | 2.50596003 |
46 | Cerebral aneurysm (HP:0004944) | 2.49769912 |
47 | Hypoplastic ischia (HP:0003175) | 2.48749610 |
48 | Sudden death (HP:0001699) | 2.47935458 |
49 | Aortic dissection (HP:0002647) | 2.47573808 |
50 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.43384622 |
51 | Malignant hyperthermia (HP:0002047) | 2.40924099 |
52 | Akinesia (HP:0002304) | 2.39008595 |
53 | Hematochezia (HP:0002573) | 2.32474658 |
54 | Lipoatrophy (HP:0100578) | 2.31248296 |
55 | Papillary thyroid carcinoma (HP:0002895) | 2.28974205 |
56 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.28637168 |
57 | Fetal akinesia sequence (HP:0001989) | 2.28400895 |
58 | Atrophic scars (HP:0001075) | 2.26497252 |
59 | Myopathic facies (HP:0002058) | 2.25968595 |
60 | Neck muscle weakness (HP:0000467) | 2.24323202 |
61 | Neurofibrillary tangles (HP:0002185) | 2.22936631 |
62 | Recurrent abscess formation (HP:0002722) | 2.20306087 |
63 | Bell-shaped thorax (HP:0001591) | 2.19795776 |
64 | Frequent falls (HP:0002359) | 2.19072233 |
65 | Abnormality of the ischium (HP:0003174) | 2.18319237 |
66 | Broad metatarsal (HP:0001783) | 2.16975480 |
67 | Spondylolisthesis (HP:0003302) | 2.16699834 |
68 | Absent phalangeal crease (HP:0006109) | 2.16315271 |
69 | Popliteal pterygium (HP:0009756) | 2.16314770 |
70 | Thick nail (HP:0001805) | 2.15525189 |
71 | Aplasia of the musculature (HP:0100854) | 2.15272790 |
72 | Calcaneovalgus deformity (HP:0001848) | 2.14995919 |
73 | Abnormal finger flexion creases (HP:0006143) | 2.14678400 |
74 | Distal lower limb muscle weakness (HP:0009053) | 2.14108616 |
75 | Right ventricular cardiomyopathy (HP:0011663) | 2.14097579 |
76 | Aneurysm (HP:0002617) | 2.13701738 |
77 | Dilatation of the ascending aorta (HP:0005111) | 2.11124401 |
78 | Bulbar palsy (HP:0001283) | 2.09486029 |
79 | Disinhibition (HP:0000734) | 2.08615796 |
80 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.06272479 |
81 | Subaortic stenosis (HP:0001682) | 2.06272479 |
82 | Abnormality of macrophages (HP:0004311) | 2.04388999 |
83 | Orchitis (HP:0100796) | 2.03013566 |
84 | Myositis (HP:0100614) | 2.02086494 |
85 | Ventricular tachycardia (HP:0004756) | 2.01851792 |
86 | Slender build (HP:0001533) | 2.01826345 |
87 | Axonal loss (HP:0003447) | 1.98397364 |
88 | Recurrent bacterial skin infections (HP:0005406) | 1.97220996 |
89 | Deformed tarsal bones (HP:0008119) | 1.95088787 |
90 | Polycythemia (HP:0001901) | 1.95007117 |
91 | Muscular dystrophy (HP:0003560) | 1.93965587 |
92 | Pterygium (HP:0001059) | 1.93272715 |
93 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.92963188 |
94 | Overgrowth (HP:0001548) | 1.91854320 |
95 | Muscle stiffness (HP:0003552) | 1.91779399 |
96 | Abnormality of placental membranes (HP:0011409) | 1.91164295 |
97 | Amniotic constriction ring (HP:0009775) | 1.91164295 |
98 | Rhabdomyolysis (HP:0003201) | 1.90297449 |
99 | Hip contracture (HP:0003273) | 1.89203410 |
100 | Acanthosis nigricans (HP:0000956) | 1.87463168 |
101 | Arterial tortuosity (HP:0005116) | 1.87241374 |
102 | Wormian bones (HP:0002645) | 1.86349193 |
103 | Ventricular arrhythmia (HP:0004308) | 1.84861834 |
104 | Shallow orbits (HP:0000586) | 1.84701445 |
105 | Lower limb amyotrophy (HP:0007210) | 1.84455640 |
106 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.84421990 |
107 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.84421990 |
108 | Myotonia (HP:0002486) | 1.84356435 |
109 | Gingivitis (HP:0000230) | 1.83818792 |
110 | Vascular tortuosity (HP:0004948) | 1.83333067 |
111 | Gingival bleeding (HP:0000225) | 1.83105809 |
112 | Amyloidosis (HP:0011034) | 1.82882593 |
113 | Mitral stenosis (HP:0001718) | 1.82543707 |
114 | Distal lower limb amyotrophy (HP:0008944) | 1.82348424 |
115 | Increased cerebral lipofuscin (HP:0011813) | 1.81447195 |
116 | Buphthalmos (HP:0000557) | 1.80854402 |
117 | Peritonitis (HP:0002586) | 1.80661666 |
118 | Abnormality of glycolipid metabolism (HP:0010969) | 1.78765995 |
119 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.78765995 |
120 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.78765995 |
121 | Back pain (HP:0003418) | 1.78398562 |
122 | Striae distensae (HP:0001065) | 1.78182959 |
123 | EMG: neuropathic changes (HP:0003445) | 1.77790286 |
124 | Prolonged bleeding time (HP:0003010) | 1.76546404 |
125 | Rimmed vacuoles (HP:0003805) | 1.76182735 |
126 | Thin ribs (HP:0000883) | 1.75707897 |
127 | Exostoses (HP:0100777) | 1.75248953 |
128 | Increased density of long bones (HP:0006392) | 1.73509599 |
129 | Cerebral inclusion bodies (HP:0100314) | 1.73178235 |
130 | Dilated cardiomyopathy (HP:0001644) | 1.73113835 |
131 | Rhinitis (HP:0012384) | 1.71579287 |
132 | Mitral valve prolapse (HP:0001634) | 1.70734505 |
133 | Chest pain (HP:0100749) | 1.70144397 |
134 | Myocardial infarction (HP:0001658) | 1.68640822 |
135 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.68279990 |
136 | Gastrointestinal infarctions (HP:0005244) | 1.64926841 |
137 | Optic neuritis (HP:0100653) | 1.64751292 |
138 | Retrobulbar optic neuritis (HP:0100654) | 1.64751292 |
139 | Abnormality of the endocardium (HP:0004306) | 1.63467797 |
140 | Metaphyseal dysplasia (HP:0100255) | 1.63273782 |
141 | Vertebral compression fractures (HP:0002953) | 1.60797408 |
142 | Fragile skin (HP:0001030) | 1.60699821 |
143 | Hypoplasia of the iris (HP:0007676) | 1.60661127 |
144 | Follicular hyperkeratosis (HP:0007502) | 1.60523978 |
145 | Atrial fibrillation (HP:0005110) | 1.58070108 |
146 | Increased IgE level (HP:0003212) | 1.56915288 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PDK3 | 4.27493149 |
2 | PDK4 | 4.27493149 |
3 | TRIB3 | 3.58980776 |
4 | PDK2 | 3.30918446 |
5 | EPHB1 | 2.99594430 |
6 | TTN | 2.97683461 |
7 | STK39 | 2.65665614 |
8 | DMPK | 2.08069051 |
9 | TESK1 | 2.03536561 |
10 | TGFBR2 | 1.95851246 |
11 | OBSCN | 1.85351395 |
12 | MAP3K6 | 1.77110550 |
13 | WNK4 | 1.70414706 |
14 | CAMK1G | 1.66683534 |
15 | ICK | 1.65172467 |
16 | STK3 | 1.61529149 |
17 | MOS | 1.58749842 |
18 | PKN2 | 1.55991776 |
19 | MAP2K3 | 1.53453474 |
20 | PTK2B | 1.51552452 |
21 | CAMK1D | 1.50924684 |
22 | PRPF4B | 1.41590101 |
23 | ZAP70 | 1.38381581 |
24 | PRKD3 | 1.35673907 |
25 | PHKG2 | 1.35358752 |
26 | PHKG1 | 1.35358752 |
27 | MAP3K13 | 1.34982503 |
28 | PIK3CG | 1.33898739 |
29 | RIPK1 | 1.31305850 |
30 | EPHB2 | 1.28884228 |
31 | NEK9 | 1.28492445 |
32 | MUSK | 1.28411349 |
33 | TBK1 | 1.23820456 |
34 | KSR2 | 1.21001355 |
35 | TIE1 | 1.19696124 |
36 | WNK1 | 1.18525790 |
37 | PIK3CA | 1.15104467 |
38 | RIPK4 | 1.13657051 |
39 | PTK6 | 1.09876627 |
40 | ERN1 | 1.09824023 |
41 | LATS1 | 1.09017343 |
42 | KSR1 | 1.08264749 |
43 | PDGFRA | 1.07687352 |
44 | MAP3K7 | 1.06757030 |
45 | FES | 1.06423686 |
46 | PKN1 | 1.06383837 |
47 | MAP3K2 | 1.05951600 |
48 | SGK3 | 1.05833842 |
49 | LRRK2 | 1.05411979 |
50 | LIMK1 | 1.03763140 |
51 | DDR2 | 1.03382099 |
52 | AKT3 | 0.99579658 |
53 | PDGFRB | 0.99406352 |
54 | TRPM7 | 0.97357856 |
55 | ILK | 0.96386009 |
56 | SIK1 | 0.94967206 |
57 | DYRK1B | 0.94802328 |
58 | STK10 | 0.93387819 |
59 | MET | 0.92848241 |
60 | JAK2 | 0.91920680 |
61 | MARK1 | 0.91442898 |
62 | CAMKK2 | 0.90473491 |
63 | CDK6 | 0.90313316 |
64 | FGFR2 | 0.89298436 |
65 | MAPK7 | 0.88569639 |
66 | JAK1 | 0.87885316 |
67 | PAK2 | 0.86636797 |
68 | HCK | 0.86474915 |
69 | SGK2 | 0.86443872 |
70 | STK38 | 0.86229715 |
71 | BMPR2 | 0.85101253 |
72 | KDR | 0.82486722 |
73 | IRAK1 | 0.82139994 |
74 | YES1 | 0.78949821 |
75 | PRKD1 | 0.78939500 |
76 | TYK2 | 0.78473691 |
77 | MAP3K1 | 0.76826482 |
78 | CSK | 0.76594572 |
79 | IKBKE | 0.76058024 |
80 | FGFR4 | 0.74462534 |
81 | FGFR3 | 0.74207354 |
82 | EPHA3 | 0.74046519 |
83 | CDC42BPA | 0.72780347 |
84 | STK24 | 0.71958012 |
85 | MAP3K5 | 0.71377631 |
86 | ROCK1 | 0.69980977 |
87 | PDK1 | 0.67775777 |
88 | NUAK1 | 0.67241993 |
89 | PDPK1 | 0.65415324 |
90 | SIK3 | 0.64301891 |
91 | LMTK2 | 0.63983885 |
92 | PIM2 | 0.63689084 |
93 | PAK3 | 0.62542633 |
94 | IRAK3 | 0.61819631 |
95 | MAP3K10 | 0.59733320 |
96 | MAPK12 | 0.59023220 |
97 | TAOK1 | 0.58954959 |
98 | MAPK4 | 0.58911427 |
99 | FLT3 | 0.58848210 |
100 | PRKAA2 | 0.58706217 |
101 | PBK | 0.58407992 |
102 | RET | 0.58321145 |
103 | MAP2K4 | 0.58249336 |
104 | FRK | 0.57851501 |
105 | FGR | 0.56210875 |
106 | GSK3A | 0.56086719 |
107 | MAPKAPK5 | 0.55913483 |
108 | MAPKAPK3 | 0.55825694 |
109 | CDK9 | 0.55169349 |
110 | FER | 0.54998094 |
111 | MAP2K1 | 0.54233529 |
112 | ROCK2 | 0.53495182 |
113 | TYRO3 | 0.52300674 |
114 | PTK2 | 0.52169418 |
115 | RAF1 | 0.51944304 |
116 | IRAK4 | 0.51879552 |
117 | KIT | 0.51310141 |
118 | MTOR | 0.51185032 |
119 | BMX | 0.50512140 |
120 | TEC | 0.50385731 |
121 | SYK | 0.48896693 |
122 | BTK | 0.48878204 |
123 | STK38L | 0.48176686 |
124 | LATS2 | 0.47215507 |
125 | MAP3K14 | 0.46952723 |
126 | INSR | 0.46939349 |
127 | TXK | 0.46171689 |
128 | PAK4 | 0.46162766 |
129 | PRKG2 | 0.45920982 |
130 | JAK3 | 0.45376034 |
131 | MAP3K12 | 0.43967316 |
132 | EGFR | 0.43810196 |
133 | MYLK | 0.43572380 |
134 | CSF1R | 0.43230343 |
135 | GRK7 | 0.41908718 |
136 | MST1R | 0.41623354 |
137 | BCR | 0.41204372 |
138 | ABL1 | 0.41002322 |
139 | PRKCQ | 0.40045843 |
140 | MARK2 | 0.36493645 |
141 | INSRR | 0.35397632 |
142 | BLK | 0.35052478 |
143 | ERBB3 | 0.33108692 |
144 | MAP3K3 | 0.30682919 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.25310846 |
2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.99342213 |
3 | Viral myocarditis_Homo sapiens_hsa05416 | 1.91218940 |
4 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.90396467 |
5 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.89339946 |
6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.87939061 |
7 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.84378807 |
8 | Focal adhesion_Homo sapiens_hsa04510 | 1.83657017 |
9 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.65948121 |
10 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.64601405 |
11 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.59320385 |
12 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.56626375 |
13 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.55624477 |
14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.52124162 |
15 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.47876262 |
16 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.46091667 |
17 | Malaria_Homo sapiens_hsa05144 | 1.45001427 |
18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.41307313 |
19 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.33875747 |
20 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.33711552 |
21 | Adherens junction_Homo sapiens_hsa04520 | 1.29714867 |
22 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.25920233 |
23 | Amoebiasis_Homo sapiens_hsa05146 | 1.21833480 |
24 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.21183687 |
25 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.19627949 |
26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.19165919 |
27 | Leishmaniasis_Homo sapiens_hsa05140 | 1.16912431 |
28 | Salmonella infection_Homo sapiens_hsa05132 | 1.14915258 |
29 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.14858641 |
30 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.13646003 |
31 | Circadian rhythm_Homo sapiens_hsa04710 | 1.12782585 |
32 | Platelet activation_Homo sapiens_hsa04611 | 1.12244354 |
33 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.11776278 |
34 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.10187864 |
35 | Pertussis_Homo sapiens_hsa05133 | 1.08022315 |
36 | Insulin resistance_Homo sapiens_hsa04931 | 1.07843673 |
37 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.07238246 |
38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.05670924 |
39 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.05121857 |
40 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.04366254 |
41 | * Endocytosis_Homo sapiens_hsa04144 | 1.03826748 |
42 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.03802081 |
43 | Tight junction_Homo sapiens_hsa04530 | 1.03672211 |
44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.01975328 |
45 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.01520107 |
46 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.01420059 |
47 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.98988532 |
48 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.97366110 |
49 | Lysosome_Homo sapiens_hsa04142 | 0.96443197 |
50 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.95850615 |
51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.94765072 |
52 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.91562673 |
53 | Other glycan degradation_Homo sapiens_hsa00511 | 0.91260744 |
54 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91062279 |
55 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.90946603 |
56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.90943751 |
57 | Endometrial cancer_Homo sapiens_hsa05213 | 0.90253826 |
58 | Axon guidance_Homo sapiens_hsa04360 | 0.89988176 |
59 | Shigellosis_Homo sapiens_hsa05131 | 0.88947864 |
60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.88916934 |
61 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.86560098 |
62 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.85356417 |
63 | Renin secretion_Homo sapiens_hsa04924 | 0.84954026 |
64 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.84885483 |
65 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84384859 |
66 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.83462619 |
67 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.83436418 |
68 | Influenza A_Homo sapiens_hsa05164 | 0.83208331 |
69 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.83129490 |
70 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.81557823 |
71 | Phagosome_Homo sapiens_hsa04145 | 0.81051759 |
72 | Tuberculosis_Homo sapiens_hsa05152 | 0.80822055 |
73 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.78723788 |
74 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.77642403 |
75 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.76314229 |
76 | Legionellosis_Homo sapiens_hsa05134 | 0.75633944 |
77 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.75319084 |
78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.75177849 |
79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.73016309 |
80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72499921 |
81 | Measles_Homo sapiens_hsa05162 | 0.72285322 |
82 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.72162010 |
83 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.71689388 |
84 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.71172663 |
85 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.71141091 |
86 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.71042430 |
87 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.69123007 |
88 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.68875214 |
89 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.67828857 |
90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.66073907 |
91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65353647 |
92 | Apoptosis_Homo sapiens_hsa04210 | 0.64531860 |
93 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63929682 |
94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63676914 |
95 | Prostate cancer_Homo sapiens_hsa05215 | 0.61666962 |
96 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61544274 |
97 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.61084999 |
98 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60754923 |
99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60590496 |
100 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.60244324 |
101 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.59805233 |
102 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.58542732 |
103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57695074 |
104 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.56544738 |
105 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56165254 |
106 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.56000235 |
107 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.55202136 |
108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54955315 |
109 | Glioma_Homo sapiens_hsa05214 | 0.54779345 |
110 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.54511265 |
111 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.54343860 |
112 | Gap junction_Homo sapiens_hsa04540 | 0.54246874 |
113 | Bladder cancer_Homo sapiens_hsa05219 | 0.54060748 |
114 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53070422 |
115 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.52991600 |
116 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.52423746 |
117 | Long-term depression_Homo sapiens_hsa04730 | 0.51957792 |
118 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51893997 |
119 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.51617121 |
120 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51090453 |
121 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50247341 |
122 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.48402498 |
123 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48224666 |
124 | Hepatitis C_Homo sapiens_hsa05160 | 0.48216011 |
125 | Pathways in cancer_Homo sapiens_hsa05200 | 0.47974861 |
126 | Hepatitis B_Homo sapiens_hsa05161 | 0.47623894 |
127 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.47114812 |
128 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.46411573 |
129 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.46350624 |